NDC properties for "Depo-testosterone 100 MG/ML Injectable Solution" (RxCUI 835831)
About this data
The tables show NDC propoerties for Depo-testosterone 100 MG/ML Injectable Solution with the RxCUI 835831
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Depo-testosterone 100 MG/ML Injectable Solution (RxCUI 835831)
| ANDA | ANDA085635 |
|---|---|
| MMSL_CODE | BD2934 |
| RxCUI | 835831 |
| SPL_SET_ID | 2f72be32-ede6-44d9-88a0-0653b53a3e47 |
| SPL_SET_ID | 735b5bf3-4464-412c-a072-1bd02f2e5380 |
| SPL_SET_ID | cfbb53d4-b868-4a28-8436-f9112eb01c39 |
| Prescribable Synonym | Depo-Testosterone 100 MG/ML Injectable Solution |
| RXNAV_STR | Depo-testosterone 100 MG/ML Injectable Solution |
| RxNorm Name | testosterone cypionate 100 MG/ML Injectable Solution [Depo-testosterone] |
| RxNorm Synonym | Depo-testosterone 100 MG/ML Injectable Solution |
| Related queries | Interactions (for RxCUI 835831) |
NDC Properties
NDC Item 00009008510
| NDC 9 | 0009-0085 |
|---|---|
| NDC 10 | 0009-0085-10 |
| NDC Item | 00009008510 |
| Packaging | 1 VIAL in 1 CARTON (0009-0085-10) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Pharmacia & Upjohn Company LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0009-0085 |
NDC Item 00009034702
| NDC 9 | 0009-0347 |
|---|---|
| NDC 10 | 0009-0347-02 |
| NDC Item | 00009034702 |
| Packaging | 1 VIAL in 1 CARTON (0009-0347-02) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Pharmacia & Upjohn Company LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1979-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0009-0347 |
NDC Item 76420042510
| NDC 9 | 76420-425 |
|---|---|
| NDC 10 | 76420-425-10 |
| NDC Item | 76420042510 |
| Packaging | 1 VIAL in 1 CARTON (76420-425-10) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Asclemed USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1979-07-25 |
| Marketing status | active |
| Related queries | Properties for NDC 9 76420-425 |
NDC Item 00009008510
| NDC 9 | 0009-0085 |
|---|---|
| NDC 10 | 0009-0085-10 |
| NDC Item | 00009008510 |
| Packaging | 1 VIAL in 1 CARTON (0009-0085-10) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Pharmacia & Upjohn Company LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0009-0085 |
NDC Item 00009034702
| NDC 9 | 0009-0347 |
|---|---|
| NDC 10 | 0009-0347-02 |
| NDC Item | 00009034702 |
| Packaging | 1 VIAL in 1 CARTON (0009-0347-02) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Pharmacia & Upjohn Company LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1979-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0009-0347 |
NDC Item 76420042510
| NDC 9 | 76420-425 |
|---|---|
| NDC 10 | 76420-425-10 |
| NDC Item | 76420042510 |
| Packaging | 1 VIAL in 1 CARTON (76420-425-10) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Asclemed USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1979-07-25 |
| Marketing status | active |
| Related queries | Properties for NDC 9 76420-425 |
NDC Item 00009008510
| NDC 9 | 0009-0085 |
|---|---|
| NDC 10 | 0009-0085-10 |
| NDC Item | 00009008510 |
| Packaging | 1 VIAL in 1 CARTON (0009-0085-10) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Pharmacia & Upjohn Company LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-07-01 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0009-0085 |
NDC Item 00009034702
| NDC 9 | 0009-0347 |
|---|---|
| NDC 10 | 0009-0347-02 |
| NDC Item | 00009034702 |
| Packaging | 1 VIAL in 1 CARTON (0009-0347-02) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Pharmacia & Upjohn Company LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1979-07-25 |
| Marketing status | ACTIVE |
| Related queries | Properties for NDC 9 0009-0347 |
NDC Item 76420042510
| NDC 9 | 76420-425 |
|---|---|
| NDC 10 | 76420-425-10 |
| NDC Item | 76420042510 |
| Packaging | 1 VIAL in 1 CARTON (76420-425-10) / 10 mL in 1 VIAL |
| ANDA | ANDA085635 |
| DCSA | CIII |
| Labeler | Asclemed USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 1979-07-25 |
| Marketing status | active |
| Related queries | Properties for NDC 9 76420-425 |